drugset / Trial / NCT02668926

Endocrine and Emotional Effects of Lisdexamfetamine and d-Amphetamine.

NCT02668926

Phase 1 Completed 24 enrolled University Hospital, Basel, Switzerland
RandomizedCrossoverQuadruple-blindBasic science

Summary

The study will compare the acute emotional and endocrine effects of equivalent doses of lisdexamfetamine and amphetamine in healthy subjects. In addition the pharmacokinetics and effects of the amphetamines on aspects of social cognition are investigated.

Timeline

Start
2016-05
Primary completion
2016-06
Completion
2016-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Dextroamphetamine Small molecule 40.3 mg Oral
Subject Lisdexamfetamine Other / unclassified 100 mg Oral

Indications

No indication recorded.